Tag: RNA
RIO DE JANEIRO, BRAZIL - Britain’s GlaxoSmithKline (GSK) and German biotech firm CureVac have teamed up in a 150 million euro deal to develop a COVID-19 vaccine next year that could target several variants with one shot.
New, more contagious...